Joseph Negri

2.2k total citations
47 papers, 1.6k citations indexed

About

Joseph Negri is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Joseph Negri has authored 47 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 16 papers in Hematology and 12 papers in Oncology. Recurrent topics in Joseph Negri's work include Multiple Myeloma Research and Treatments (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Ubiquitin and proteasome pathways (6 papers). Joseph Negri is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Ubiquitin and proteasome pathways (6 papers). Joseph Negri collaborates with scholars based in United States, Greece and Switzerland. Joseph Negri's co-authors include Constantine S. Mitsiades, Douglas W. McMillin, Nicholas Mitsiades, Vassiliki Poulaki, Jake Delmore, Paul G. Richardson, Kenneth C. Anderson, Nikhil C. Munshi, Galinos Fanourakis and Ciaran J. McMullan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Joseph Negri

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Negri United States 21 933 613 271 219 181 47 1.6k
Keiichiro Okuhira Japan 26 1.7k 1.8× 817 1.3× 249 0.9× 248 1.1× 120 0.7× 62 2.4k
Malin Wickström Sweden 27 1.3k 1.4× 650 1.1× 246 0.9× 420 1.9× 32 0.2× 63 2.2k
Fengjuan Fan China 24 1.3k 1.3× 461 0.8× 234 0.9× 349 1.6× 47 0.3× 67 1.9k
Remco J. Molenaar Netherlands 25 1.1k 1.2× 429 0.7× 177 0.7× 733 3.3× 89 0.5× 63 2.2k
Giuliana Pelicci Italy 20 2.2k 2.3× 810 1.3× 108 0.4× 548 2.5× 128 0.7× 37 2.9k
Andreas Gschwind Germany 9 1.6k 1.8× 1.1k 1.8× 117 0.4× 311 1.4× 78 0.4× 10 2.7k
Valeria Bertagnolo Italy 25 1.5k 1.6× 345 0.6× 247 0.9× 256 1.2× 43 0.2× 85 2.0k
Stefan Hart Singapore 23 1.4k 1.5× 1.0k 1.7× 326 1.2× 263 1.2× 64 0.4× 30 2.7k
Azucena Esparís‐Ogando Spain 27 1.3k 1.4× 861 1.4× 145 0.5× 262 1.2× 44 0.2× 45 2.0k
Alessandra Pattarozzi Italy 31 1.0k 1.1× 815 1.3× 63 0.2× 329 1.5× 306 1.7× 51 2.1k

Countries citing papers authored by Joseph Negri

Since Specialization
Citations

This map shows the geographic impact of Joseph Negri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Negri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Negri more than expected).

Fields of papers citing papers by Joseph Negri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Negri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Negri. The network helps show where Joseph Negri may publish in the future.

Co-authorship network of co-authors of Joseph Negri

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Negri. A scholar is included among the top collaborators of Joseph Negri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Negri. Joseph Negri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsieh, Yi‐Chen, Joseph Negri, Amy He, et al.. (2022). Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity. Molecular Neurodegeneration. 17(1). 61–61. 7 indexed citations
2.
Negri, Joseph, Vilas Menon, & Tracy L. Young‐Pearse. (2020). Assessment of Spontaneous Neuronal ActivityIn VitroUsing Multi-Well Multi-Electrode Arrays: Implications for Assay Development. eNeuro. 7(1). ENEURO.0080–19.2019. 36 indexed citations
3.
Nagiec, M. Marek, Jeremy R. Duvall, Adam Skepner, et al.. (2018). Novel tricyclic glycal-basedTRIB1inducers that reprogram LDL metabolism in hepatic cells. MedChemComm. 9(11). 1831–1842. 5 indexed citations
4.
Muratore, Christina, Mei-Chen Liao, Marty A. Fernandez, et al.. (2017). Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability. Stem Cell Reports. 9(6). 1868–1884. 60 indexed citations
5.
Nagiec, M. Marek, Adam Skepner, Joseph Negri, et al.. (2015). Modulators of Hepatic Lipoprotein Metabolism Identified in a Search for Small-Molecule Inducers of Tribbles Pseudokinase 1 Expression. PLoS ONE. 10(3). e0120295–e0120295. 28 indexed citations
6.
Negri, Joseph, et al.. (2013). Automated quantification of Zebrafish tail deformation for high-throughput drug screening. PubMed. 902–905. 6 indexed citations
7.
Deakyne, Julianna S., Fei Huang, Joseph Negri, et al.. (2013). Analysis of the Activities of RAD54, a SWI2/SNF2 Protein, Using a Specific Small-molecule Inhibitor. Journal of Biological Chemistry. 288(44). 31567–31580. 15 indexed citations
8.
McMillin, Douglas W., Joseph Negri, & Constantine S. Mitsiades. (2013). The role of tumour–stromal interactions in modifying drug response: challenges and opportunities. Nature Reviews Drug Discovery. 12(3). 217–228. 365 indexed citations
9.
Kitami, Toshimori, David J. Logan, Joseph Negri, et al.. (2012). A Chemical Screen Probing the Relationship between Mitochondrial Content and Cell Size. PLoS ONE. 7(3). e33755–e33755. 45 indexed citations
10.
McMillin, Douglas W., Jake Delmore, Joseph Negri, et al.. (2012). Compartment-specific bioluminescence imaging platform for the high-throughput evaluation of antitumor immune function. Blood. 119(15). e131–e138. 24 indexed citations
11.
Jakubı́ková, Jana, David Cervi, Melissa Ooi, et al.. (2011). Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. Haematologica. 96(8). 1170–1179. 63 indexed citations
12.
McMillin, Douglas W., Jake Delmore, Joseph Negri, et al.. (2011). Molecular and cellular effects of multi‐targeted cyclin‐dependent kinase inhibition in myeloma: biological and clinical implications. British Journal of Haematology. 152(4). 420–432. 24 indexed citations
13.
McMillin, Douglas W., Jake Delmore, Ellen Weisberg, et al.. (2010). Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity. Nature Medicine. 16(4). 483–489. 236 indexed citations
14.
McMillin, Douglas W., Melissa Ooi, Jake Delmore, et al.. (2009). Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235. Cancer Research. 69(14). 5835–5842. 105 indexed citations
15.
Negri, Joseph, Douglas W. McMillin, Jake Delmore, et al.. (2009). In vitro anti‐myeloma activity of the Aurora kinase inhibitor VE‐465. British Journal of Haematology. 147(5). 672–676. 26 indexed citations
16.
Mitsiades, Constantine S., Joseph Negri, Ciaran J. McMullan, et al.. (2007). Targeting BRAFV600E in thyroid carcinoma: therapeutic implications. Molecular Cancer Therapeutics. 6(3). 1070–1078. 43 indexed citations
17.
Mitsiades, Constantine S., Patrick Hayden, Vassiliki Kotoula, et al.. (2007). Bcl-2 Overexpression in Thyroid Carcinoma Cells Increases Sensitivity to Bcl-2 Homology 3 Domain Inhibition. The Journal of Clinical Endocrinology & Metabolism. 92(12). 4845–4852. 24 indexed citations
18.
Negri, Joseph, Douglas W. McMillin, Nicholas Mitsiades, et al.. (2006). Anti-Myeloma Activity of the Small-Molecule Aurora Kinase Inhibitor VE465.. Blood. 108(11). 3468–3468. 2 indexed citations
19.
Mitsiades, Constantine, Nicholas Mitsiades, Joseph Negri, et al.. (2004). IPI-504: A Novel hsp90 Inhibitor with In Vitro and In Vivo Anti-Tumor Activity.. Blood. 104(11). 2403–2403. 6 indexed citations
20.
Nicolas, M., Joseph Negri, & J.P. Burger. (1990). Decoupling and reversibility phenomena induced by low fields and hydrogen absorption for superconducting (4334) and (2223) bismuth compounds and EuBa2Cu3O7. Journal of the Less Common Metals. 164-165. 1076–1083. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiichiro Okuhira Breakdown of academic impact, for papers by Malin Wickström Breakdown of academic impact, for papers by Fengjuan Fan Breakdown of academic impact, for papers by Remco J. Molenaar Breakdown of academic impact, for papers by Giuliana Pelicci Breakdown of academic impact, for papers by Andreas Gschwind Breakdown of academic impact, for papers by Valeria Bertagnolo Breakdown of academic impact, for papers by Stefan Hart Breakdown of academic impact, for papers by Azucena Esparís‐Ogando Breakdown of academic impact, for papers by Alessandra Pattarozzi
Rankless by CCL
2026